Lysine residues of ABCA1 are required for the interaction with apoA-I
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids - Tập 1821 - Trang 530-535 - 2012
Tài liệu tham khảo
Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat. Genet., 22, 336, 10.1038/11905
Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat. Genet., 22, 347, 10.1038/11914
Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat. Genet., 22, 352, 10.1038/11921
Fitzgerald, 2002, Naturally occurring mutations in ABCA1's largest extracellular loops can disrupt its direct interaction with apolipoprotein A-I, J. Biol. Chem., 277, 33178, 10.1074/jbc.M204996200
Oram, 2000, ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages, J. Biol. Chem., 275, 34508, 10.1074/jbc.M006738200
Wang, 2000, Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1, J. Biol. Chem., 275, 33053, 10.1074/jbc.M005438200
Chroni, 2004, Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1, Biochemistry, 43, 2126, 10.1021/bi035813p
Tanaka, 2001, Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's Syndrome, Biochem. Biophys. Res. Commun., 283, 1019, 10.1006/bbrc.2001.4891
Peelman, 2003, Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology, J. Mol. Biol., 325, 259, 10.1016/S0022-2836(02)01105-1
Hozoji, 2009, Formation of two intramolecular disulfide bonds is necessary for ApoA-I-dependent cholesterol efflux mediated by ABCA1, J. Biol. Chem., 284, 11293, 10.1074/jbc.M900580200
Lin, 2000, Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol, Atherosclerosis, 149, 359, 10.1016/S0021-9150(99)00503-1
Hassan, 2007, Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis, J. Lipid Res., 48, 2428, 10.1194/jlr.M700206-JLR200
Vedhachalam, 2007, Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles, J. Biol. Chem., 282, 25123, 10.1074/jbc.M704590200
Vedhachalam, 2007, ABCA1-induced cell surface binding sites for ApoA-I, Arterioscler. Thromb. Vasc. Biol., 27, 1603, 10.1161/ATVBAHA.107.145789
Goldstein, 1985, Receptor-mediated endocytosis: concepts emerging from the LDL receptor system, Annu. Rev. Cell Biol., 1, 1, 10.1146/annurev.cb.01.110185.000245
Munehira, 2004, Alpha1-syntrophin modulates turnover of ABCA1, J. Biol. Chem., 279, 15091, 10.1074/jbc.M313436200
Azuma, 2009, Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation, Genes Cells, 14, 191, 10.1111/j.1365-2443.2008.01261.x
Vaughan, 2003, ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions, J. Lipid Res., 44, 1373, 10.1194/jlr.M300078-JLR200
Tanaka, 2003, Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis, J. Biol. Chem., 278, 8815, 10.1074/jbc.M206885200
Goldstein, 1976, Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans, Cell, 7, 85, 10.1016/0092-8674(76)90258-0
Brown, 1978, Inhibition of the binding of low-density lipoprotein to its cell surface receptor in human fibroblasts by positively charged proteins, J. Supramol. Struct., 8, 223, 10.1002/jss.400080302
Nagao, 2009, Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation, J. Lipid Res., 50, 1165, 10.1194/jlr.M800597-JLR200
Ajees, 2006, Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases, Proc. Natl. Acad. Sci. U. S. A., 103, 2126, 10.1073/pnas.0506877103
Chambenoit, 2001, Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter, J. Biol. Chem., 276, 9955, 10.1074/jbc.M010265200
Takahashi, 2006, Purification and ATPase activity of human ABCA1, J. Biol. Chem., 281, 10760, 10.1074/jbc.M513783200
Mulya, 2007, Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1, Arterioscler. Thromb. Vasc. Biol., 27, 1828, 10.1161/ATVBAHA.107.142455
Davidson, 2007, The structure of apolipoprotein A-I in high density lipoproteins, J. Biol. Chem., 282, 22249, 10.1074/jbc.R700014200
Smith, 2002, Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux, J. Biol. Chem., 277, 17797, 10.1074/jbc.M201594200
Smith, 2010, The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein A-I in lipid binding and ABCA1-mediated cholesterol efflux, Biochim. Biophys. Acta, 1801, 64, 10.1016/j.bbalip.2009.09.012